Life Therapeutics Limited http://www.alacrastore.com/company-snapshot/Life_Therapeutics_Limited-2105419 Wednesday, October 08, 2008 1:11:37 AM 2105419 Life Therapeutics Limited en AlacraStore RSS Builder 1.0 30 http://www.alacrastore.com/storecontent/bir/1204553bir/1204553normLife Therapeutics Ltd.AustraliaServices: Research, development, manufacture and sale of separation technologies for the life sciences market and blood clotting tests for genetic disorders for the health industry. Gradipore's technologies and products enable research, development and pr87312833382650475417103254113345164234509EGLFE9/16/2008 6:58:44 AM1204553Company Profiles & FinancialsGale Company ProfilesAUSTRALIA - Aegis Partners Ltd agreed to acquire a ##% stake, or ##.### mil ordinary shares, in Life Therapeutics Ltd, a biotechnology company, for #.## Australian dollar (#.### British pound/$#.### US) per share, or a total value of A$#.### mil (#.### mil pounds/$#.### mil), in a privately negotiated transaction.6/17/2008 4:48:04 PM98558Q53241R98558Q53241RAegis Partners LtdLife Therapeutics LtdAegis Partners LtdLife Therapeutics Ltdhttp://www.alacrastore.com/storecontent/Thomson_M%26A/Aegis_Partners_Ltd_acquires_a_minority_stake_in_Life_Therapeutics_Ltd-1986894040sdc/19868940401986894040Copyright © 2008, Thomson Financial, All Rights ReservedInvestment & Commodity Firms,Dealers,ExchangesUnited KingdomInvestment advice6282FFForeignPrivate6282:Investment advice6289:Security and commodity services, nec6282:Investment advice6289:Security and commodity services, necAustraliaDrugsAustraliaBiological products, except diagnostic substances2836FFForeignPublicLFE7992001Pvd finl svcsBiotech coCashCash OnlyOrdinary Share390940002Jun 17 20080.000000.000000.000000.000000.000000.000000.000000.000000.000000.000000.000000.000000.000000.000000.000000.000000.000000.000000.000000.000000.000000.000000.000000.000001.000002.000003.00000Aegis Partners Ltd, based inLondon, provides financialservices.Aegis Partners Ltd, based in London, provides financialservices.Aegis Partners Ltd, based in London, provides financial services.1.000002.000003.000004.000005.000006.000007.000008.000009.0000010.0000011.0000012.0000013.0000014.0000015.0000016.0000017.0000018.0000019.0000020.0000021.0000022.00000Life Therapeutics Ltd, locatedin New South Wales, is abiotechnology companyspecializing on plasma-derivedproducts - from collection tocommercialization. Thecompany's business unitsinclude the Life Sera, whichprovides hyperimmune plasmafor the manufacture of lifesaving therapies frommuch-needed disease statedonors such as HIV, HBV andCMV; Life Diagnostics, whichprovides highly specificdiagnostic tests forblood-borne diseases andblood-clotting disorders; andthe NuSep (formerly lifeGels), which precast gels andlaboratory separationprocesses.Life Therapeutics Ltd, located in New South Wales, is abiotechnology company specializing on plasma-derivedproducts - from collection to commercialization. Thecompany's business units include the Life Sera, whichprovides hyperimmune plasma for the manufacture of lifesaving therapies from much-needed disease state donors suchas HIV, HBV and CMV; Life Diagnostics, which provides highlyspecific diagnostic tests for blood-borne diseases andblood-clotting disorders; and the NuSep (formerly lifeGels), which precast gels and laboratory separationprocesses.Life Therapeutics Ltd, located in New South Wales, is a biotechnology company specializing on plasma-derived products - from collection to commercialization. The company's business units include the Life Sera, which provides hyperimmune plasma for the manufacture of life saving therapies from much-needed disease state donors such as HIV, HBV and CMV; Life Diagnostics, which provides highly specific diagnostic tests for blood-borne diseases and blood-clotting disorders; and the NuSep (formerly life Gels), which precast gels and laboratory separation processes.0.000000.000000.00000123.22000YAustralian Dollar16 Jun 08Mon, 16 Jun 2008 00:00:00 ESTDate Announced: 06/16/2008Date Effective:Acq. Part. Int.Friendly0.000000.000000.000000.000000.000000.07000Price/Share0.000001.294 Australian Dollar1.294008.626001.294 Australian Dollar1.294000.000000.000000.066000.066001.294001.294 Australian Dollar0.93900N0.624000.000000.000000.000000.000000.000001.215001.215000.000000.000000.000000.000000.000000.000000.0000015.000000.000000.000000.000000.000000.000000.000000.000000.000000.000000.084000.080000.086000.000000.000000.000000.000000.000000.000000.0000010.416000.000000.000000.000000.000000.00000-22.22000-21.35000-16.670001.000002.000003.000004.000005.000006.000007.000008.000009.0000010.0000011.0000012.00000AUSTRALIA - Aegis Partners Ltdagreed to acquire a 15% stake,or 18.484 mil ordinary shares,in Life Therapeutics Ltd, abiotechnology company, for0.07 Australian dollar (0.034British pound/$0.066 US) pershare, or a total value ofA$1.294 mil (0.624 milpounds/$1.215 mil), in aprivately negotiatedtransaction.AUSTRALIA - Aegis Partners Ltd agreed to acquire a 15% stake, or 18.484 mil ordinary shares, in Life Therapeutics Ltd, a biotechnology company, for 0.07 Australian dollar (0.034 British pound/$0.066 US) per share, or a total value of A$1.294 mil (0.624 mil pounds/$1.215 mil), in a privately negotiated transaction.AUSTRALIA - Aegis Partners Ltd agreed to acquire a 15% stake, or 18.484 mil ordinaryshares, in Life Therapeutics Ltd, a biotechnology company, for 0.07 Australian dollar(0.034 British pound/$0.066 US) per share, or a total value of A$1.294 mil (0.624 milpounds/$1.215 mil), in a privately negotiated transaction.AUSTRALIA - Aegis Partners Ltd agreed to acquire a 15% stake, or 18.484 mil ordinary shares, in Life Therapeutics Ltd, a biotechnology company, for 0.07 Australian dollar (0.034 British pound/$0.066US) per share, or a total value of A$1.294 mil (0.624 mil pounds/$1.215 mil), in a privately negotiated transaction.AUSTRALIA - Aegis Partners Ltd agreed to acquire a 15% stake, or 18.484 mil ordinary shares, in Life Therapeutics Ltd, a biotechnologycompany, for 0.07 Australian dollar (0.034 British pound/$0.066 US) per share, or a total value of A$1.294 mil (0.624 mil pounds/$1.215mil), in a privately negotiated transaction.Pending0.000000.000000.000000.000000.000000.000000.000000.000000.000000.000000.000000.000000.000000.000000.000000.000000.000000.000000.000000.000000.000000.000000.000000.000000.000000.000000.000000.000000.000000.000000.000000.000000.000000.000000.000000.000000.000000.000000.000000.000000.000000.000000.000000.000000.000000.000000.000000.000000.00000Status:Pending-999.00000np0.00000-999.00000np0.000000.000000.000000.000000.000000.000000.000000.000000.000000.000000.000002836:Biological products, except diagnostic substances8071:Medical laboratories8731:Commercial physical and biological research8733:Noncommercial research organizations7992001United Kingdom6282ForeignPrivate2836:Biological products, except diagnostic substances8071:Medical laboratories8731:Commercial physical and biological research8733:Noncommercial research organizations390940002AustraliaAustralia2836ForeignPublicLFE1.215001.294001.215000.62400Deal InformationTF Mergers & Acquisitions